Exercise testing in girls with Turner Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess exercise tolerance in girls aged 8-18 years with Turner Syndrome by conducting cardiopulmonary exercise tests. The study will compare the VO2 max of participants to standard values and evaluate how cardiovascular parameters such as heart rate and blood pressure change during exercise. Participants will undergo a standardized cyclo-ergometry test to gather data on their exercise capacity and cardiovascular response.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Turner syndrome girls aged 8-18 years old

Exclusion Criteria:

* Severe mental impairement making it impossible to perform an exercise test

Where it's running

• Ghent University Hospital
  Ghent, Belgium Recruiting

Study contacts

• Study coordinator: Dr. Debo
• Email: bauke.debo@uzgent.be
• Phone: 093329813

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inpegsomatropin vs Givopegsomatropin for short stature in girls with Turner syndrome

  A 52-week, multicenter, randomized study tests whether Inpegsomatropin injections help prepubertal girls with Turner syndrome grow taller compared with a known treatment.

  Recruiting at 49 sites Phase 3 Xiamen Amoytop Biotech Co., Ltd. · Anyang and 50 other locations · NCT07614152

• Parental plans and pregnancy outcomes in 93 women with Turner syndrome

  This project describes parental plans and pregnancy outcomes for adult women with Turner syndrome treated at Strasbourg University Hospitals between 2009 and 2019.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07344012

• Once-weekly lonapegsomatropin versus daily somatropin for children and adolescents with short stature due to growth-hormone-sufficient conditions

  It will test whether a once-weekly injection of lonapegsomatropin helps children and teens with Turner syndrome, SHOX mutation, small-for-gestational-age, or idiopathic short stature grow as well as or better than daily somatropin.

  Recruiting at 56 sites Phase 3 Ascendis Pharma A/S · Phoenix, Arizona and 55 other locations · NCT07221851

• Bleeding patterns with sequential versus continuous progesterone in adolescents with Turner syndrome

  This study will test whether taking progesterone continuously or in a sequential (monthly) schedule changes bleeding patterns in adolescents with Turner syndrome who are on estrogen replacement therapy.

  Recruiting Phase 4 Children's Mercy Hospital Kansas City · Kansas City, Missouri · NCT06834594

• Investigating liver health in adults with Turner Syndrome

  This study looks at liver health in adults with Turner Syndrome to see how common liver problems are and what might cause them.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06794190

• Comparing oral and transdermal estrogen therapy in women with Turner syndrome

  This study is testing whether taking estrogen as a pill or through the skin is better for women with Turner syndrome in terms of their overall health and well-being.

  Recruiting Phase 4 University of Aarhus · Aarhus, Aarhus N · NCT06570460

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.